190 related articles for article (PubMed ID: 32442424)
41. Cyanorona-20: The first potent anti-SARS-CoV-2 agent.
Rabie AM
Int Immunopharmacol; 2021 Sep; 98():107831. PubMed ID: 34247016
[TBL] [Abstract][Full Text] [Related]
42. Allosteric inhibition of dengue virus RNA-dependent RNA polymerase by
Panday H; Jha SK; Al-Shehri M; Panda SP; Rana R; Alwathinani NF; Azhar EI; Dwivedi VD; Jha AK
J Biomol Struct Dyn; 2024 Jul; 42(10):5402-5414. PubMed ID: 38764132
[TBL] [Abstract][Full Text] [Related]
43. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis.
Hoffmann HH; Kunz A; Simon VA; Palese P; Shaw ML
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5777-82. PubMed ID: 21436031
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid.
Hung HC; Chen TC; Fang MY; Yen KJ; Shih SR; Hsu JT; Tseng CP
J Antimicrob Chemother; 2010 Apr; 65(4):676-83. PubMed ID: 20089540
[TBL] [Abstract][Full Text] [Related]
45. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
46. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
Zhang L; Zhou R
J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
[TBL] [Abstract][Full Text] [Related]
47. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
48. Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro.
Kim YJ; Cubitt B; Cai Y; Kuhn JH; Vitt D; Kohlhof H; de la Torre JC
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751087
[TBL] [Abstract][Full Text] [Related]
49. Incorporation efficiency and inhibition mechanism of 2'-substituted nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase.
Yuan C; Goonetilleke EC; Unarta IC; Huang X
Phys Chem Chem Phys; 2021 Sep; 23(36):20117-20128. PubMed ID: 34514487
[TBL] [Abstract][Full Text] [Related]
50. 1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.
Nyanguile O; Pauwels F; Van den Broeck W; Boutton CW; Quirynen L; Ivens T; van der Helm L; Vandercruyssen G; Mostmans W; Delouvroy F; Dehertogh P; Cummings MD; Bonfanti JF; Simmen KA; Raboisson P
Antimicrob Agents Chemother; 2008 Dec; 52(12):4420-31. PubMed ID: 18852280
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity.
Cox RM; Sourimant J; Govindarajan M; Natchus MG; Plemper RK
PLoS Pathog; 2021 Feb; 17(2):e1009371. PubMed ID: 33621266
[TBL] [Abstract][Full Text] [Related]
52. A naturally occurring antiviral ribonucleotide encoded by the human genome.
Gizzi AS; Grove TL; Arnold JJ; Jose J; Jangra RK; Garforth SJ; Du Q; Cahill SM; Dulyaninova NG; Love JD; Chandran K; Bresnick AR; Cameron CE; Almo SC
Nature; 2018 Jun; 558(7711):610-614. PubMed ID: 29925952
[TBL] [Abstract][Full Text] [Related]
53. CX-6258 hydrochloride hydrate: A potential non-nucleoside inhibitor targeting the RNA-dependent RNA polymerase of norovirus.
Liu Y; Li Q; Shao H; Mao Y; Liu L; Yi D; Duan Z; Lv H; Cen S
Virology; 2024 Jul; 595():110088. PubMed ID: 38643657
[TBL] [Abstract][Full Text] [Related]
54. Potentiation of antimetabolite action by uridylate trapping.
Keppler D; Holstege A; Weckbecker G; Fauler J; Gasser T
Adv Enzyme Regul; 1985; 24():417-27. PubMed ID: 3835824
[TBL] [Abstract][Full Text] [Related]
55. Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin.
Yin W; Luan X; Li Z; Zhou Z; Wang Q; Gao M; Wang X; Zhou F; Shi J; You E; Liu M; Wang Q; Jiang Y; Jiang H; Xiao G; Zhang L; Yu X; Zhang S; Eric Xu H
Nat Struct Mol Biol; 2021 Mar; 28(3):319-325. PubMed ID: 33674802
[TBL] [Abstract][Full Text] [Related]
56. Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase.
Wu JZ; Yao N; Walker M; Hong Z
Mini Rev Med Chem; 2005 Dec; 5(12):1103-12. PubMed ID: 16375756
[TBL] [Abstract][Full Text] [Related]
57. Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase.
Sangawa H; Komeno T; Nishikawa H; Yoshida A; Takahashi K; Nomura N; Furuta Y
Antimicrob Agents Chemother; 2013 Nov; 57(11):5202-8. PubMed ID: 23917318
[TBL] [Abstract][Full Text] [Related]
58. Key role of uridine kinase and uridine phosphorylase in the homeostatic regulation of purine and pyrimidine salvage in brain.
Balestri F; Barsotti C; Lutzemberger L; Camici M; Ipata PL
Neurochem Int; 2007 Dec; 51(8):517-23. PubMed ID: 17643556
[TBL] [Abstract][Full Text] [Related]
59. 1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors.
Pismataro MC; Felicetti T; Bertagnin C; Nizi MG; Bonomini A; Barreca ML; Cecchetti V; Jochmans D; De Jonghe S; Neyts J; Loregian A; Tabarrini O; Massari S
Eur J Med Chem; 2021 Oct; 221():113494. PubMed ID: 33962311
[TBL] [Abstract][Full Text] [Related]
60. Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymerase.
Ding Y; Girardet JL; Smith KL; Larson G; Prigaro B; Wu JZ; Yao N
Bioorg Chem; 2006 Feb; 34(1):26-38. PubMed ID: 16360193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
